Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, septiembre 26
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Rain Enhancement Technologies Holdco Inc
RAIN
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.9996
-0.0104
-1.03%
al cierre: Sep 25, 5:00 PM EST
$1.01
0.0089
0.89%
After hour: 7:10 PM EST
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Rain Enhancement Financials
Rain Enhancement (RAIN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Rain Enhancement Q1 EPS $(0.24), Sales $10.500K
Rain Enhancement (NASDAQ:RAIN) reported quarterly losses of $(0.24) per share. The company reported $10.500 thousand in sales this quarter.
Benzinga Newsdesk
PRO
Rain Enhancement Q4 EPS $(0.59)
Rain Enhancement (NASDAQ:RAIN) reported quarterly losses of $(0.59) per share.
Benzinga Newsdesk
PRO
Rain Oncology Q3 EPS $(0.19) Beats $(0.27) Estimate
Rain Oncology (NASDAQ:RAIN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 72.06 percent increase over losses of $(0.68) per share from the
Benzinga Newsdesk
PRO
Rain Oncology Q2 EPS $(0.61) Misses $(0.51) Estimate
Rain Oncology (NASDAQ:RAIN) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.51) by 19.61 percent. This is a 7.58 percent increase over losses of $(0.66) per share from
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Benzinga Insights
Dow Tumbles 100 Points; Micron Technology Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping over 100 points on Monday. The Dow traded down 0.36% to 33,306.30 while the NASDAQ rose 0.39% to 12,707.21. The S&P 500, also rose, gaining, 0.05% to 4,194.07.
Lisa Levin
Privacy Manager